Gil Bashe Gil Bashe

Gil Bashe is Managing Partner, Global Health at Finn Partners. Gil can be reached on Twitter @Gil_Bashe.

A New Age in Pricing

Medicines are the preferred path to arrest disease and restore health. And while scientists ...

Say Goodbye to FDA Complacency

Too many people think the Food and Drug Administration (FDA) favors predictability over speed. ...

The Art of Indecision

Caution: We are entering a climate of uncertainty, where the natural response is a ...

From Obamacare to Trumpcare: America Readies for Change

The Affordable Care Act (ACA) has been a magnet for heated Beltway conversation since ...

Is the Consumer Still King?

Thirty years ago, medical marketing history was made with the launch of the first ...

Can the Shine be Restored to Pharma’s Tarnished Reputation Crown?

Hydro-fracturing (i.e., fracking) and tobacco have long endured societal disdain. Tolerating public abuse has ...

Reaffirmed ACA Shifts Business as Usual

Regardless of how health executives called the recent King v. Burwell coin toss, the ...

The Important Role of Advocacy in Keeping Care Before Cost

Connecting with patients and groups representing their therapeutic and psychosocial needs has long been ...

If You Build It—They Will Come!

Field of Dreams remains the classic movie that continues to spark creative imagination. “If ...

The Difficult Art of Restraint

This is a time when biopharma brands are structured around integrated communications in order ...

PM360 Q & A with Bruno Cohen, Chairman of the Galien Foundation

The Galien Foundation’s impact on the international medical innovation community is unmistakable. Founded in ...

Open the New Health Customer Floodgates

Whatever you think of the Affordable Care Act (ACA), from website snags to promise ...